Th17 related cytokines in acute myeloid leukemia

Frontiers in Bioscience

Volumn 17, Issue 6, 2011, Pages 2284-2294

  Li, Peng ^a   Ji, Min ^a,c   Park, Jino ^c   Bunting, Kevin D ^b   Ji, Chunyan ^a   Tse, William ^c  

^a SHANDONG UNIVERSITY   (China)

^b EMORY UNIVERSITY   (United States)

^c WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

AML; Cytokines; IL 17; IL 1beta; IL 21; IL 23; IL 6; Pathogenesis; Review; TGF beta; Th17 cells

Indexed keywords

EID: 84860271400     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4052     Document Type: Review

References (102)

1. L. E. Harrington, R. D. Hatton, P. R. Mangan, H. Turner, T. L. Murphy, K. M. Murphy and C. T. Weaver: Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6, 1123-1132 (2005) (Pubitemid 41541790)
2. H. Park, Z. Li, X. O. Yang, S. H. Chang, R. Nurieva, Y. H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian and C. Dong: A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6, 1133-1141 (2005) (Pubitemid 41541791)
3. T. R. Mosmann and R. L. Coffman: TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7, 145-173 (1989) (Pubitemid 19138011)
4. K. M. Murphy and S. L. Reiner: The lineage decisions of helper T cells. Nat Rev Immunol 2, 933-944 (2002) (Pubitemid 37323214)
5. A. K. Abbas, K. M. Murphy and A. Sher: Functional diversity of helper T lymphocytes. Nature 383, 787-793 (1996) (Pubitemid 26372655)
6. N. Street and T. Mosmann: Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J 5, 171-177 (1991) (Pubitemid 21892876)
7. T. R. Mosmann and S. Sad: The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17, 138-146 (1996) (Pubitemid 26074503)
8. T. A. Wynn: TH-17: a giant step from TH1 and TH2. Nat Immunol 6, 1069-1070 (2005)
9. P. Schwarzenberger and J. K. Kolls: Interleukin 17: An example for gene therapy as a tool to study cytokine mediated regulation of hematopoiesis. J Cell Biochem 85, 88-95 (2002) (Pubitemid 34477671)
10. L. A. Tesmer, S. K. Lundy, S. Sarkar and D. A. Fox: Th17 cells in human disease. Immunol Rev 223, 87-113 (2008) (Pubitemid 351986173)
11. E. Bettelli, M. Oukka and V. K. Kuchroo: TH-17 cells in the circle of immunity and autoimmunity. Nat Immunol 8, 345-350 (2007) (Pubitemid 46745409)
12. Y. Zheng, D. M. Danilenko, P. Valdez, I. Kasman, J. Eastham-Anderson, J. Wu and W. Ouyang: Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445, 648-651 (2007) (Pubitemid 46232884)
13. C. A. Murphy, C. L. Langrish, Y. Chen, W. Blumenschein, T. McClanahan, R. A. Kastelein, J. D. Sedgwick and D. J. Cua: Divergent pro-and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 198, 1951-1957 (2003) (Pubitemid 38032126)
14. D. J. Cua, J. Sherlock, Y. Chen, C. A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, S. Zurawski, M. Wiekowski, S. A. Lira, D. Gorman, R. A. Kastelein and J. D. Sedgwick: Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744-748 (2003) (Pubitemid 36227625)
15. Y. Miyahara, K. Odunsi, W. Chen, G. Peng, J. Matsuzaki and R. F. Wang: Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer. Proc Natl Acad Sci USA 105, 15505-15510 (2008)
16. B. Zhang, G. Rong, H. Wei, M. Zhang, J. Bi, L. Ma, X. Xue, G. Wei, X. Liu and G. Fang: The prevalence of Th17 cells in patients with gastric cancer. Biochem and Biophys Res Commun 374, 533-537 (2008)
17. J. P. Zhang, J. Yan, J. Xu, X. H. Pang, M. S. Chen, L. Li, C. Wu, S. P. Li and L. Zheng: Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J Hepatol 50, 980-989 (2009)
18. I. Kryczek, S. Wei, L. Zou, S. Altuwaijri, W. Szeliga, J. Kolls, A. Chang and W. Zou: Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J Immunol 178, 6730-6733 (2007) (Pubitemid 46847396)
19. B. Lowenberg, J. R. Downing and A. Burnett: Acute myeloid leukemia. N Engl J Med 341, 1051-1062 (1999) (Pubitemid 29451802)
20. E. Estey and H. Döhner: Acute myeloid leukaemia. The Lancet 368, 1894-1907 (2006) (Pubitemid 44794525)
21. R. Fritsche-Polanz, M. Fritz, A. Huber, K. Sotlar, W. R. Sperr, C. Mannhalter, M. Fodinger and P. Valent: High frequency of concomitant mastocytosis in patients with acute myeloid leukemia exhibiting the transforming KIT mutation D816V. Mol Oncol 4, 335-346 (2010)
22. R. K. Severson and J. A. Ross: The causes of acute leukemia. Curr opin oncol 11, 20-24 (1999) (Pubitemid 29082050)
23. C. Wu, S. Wang, F. Wang, Q. Chen, S. Peng, Y. Zhang, J. Qian, J. Jin and H. Xu: Increased frequencies of T helper type 17 cells in the peripheral blood of patients with acute myeloid leukaemia. Clin Exp Immunol 158, 199-204 (2009)
24. S. Aggarwal, N. Ghilardi, M. H. Xie, F. J. de Sauvage and A. L. Gurney: Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 278, 1910-1914 (2003) (Pubitemid 36801431)
25. M. Veldhoen, R. J. Hocking, R. A. Flavell and B. Stockinger: Signals mediated by transforming growth factorbeta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat Immunol 7, 1151-1156 (2006) (Pubitemid 44594310)
26. M. Veldhoen, R. J. Hocking, C. J. Atkins, R. M. Locksley and B. Stockinger: TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24, 179-189 (2006) (Pubitemid 43214587)
27. E. Bettelli, Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner and V. K. Kuchroo: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235-238 (2006)
28. Y. Laouar, F. S. Sutterwala, L. Gorelik and R. A. Flavell: Transforming growth factor-[beta] controls T helper type 1 cell development through regulation of natural killer cell interferon-[gamma]. Nat Immunol 6, 600-607 (2005) (Pubitemid 41710731)
29. J. T. Lin, S. L. Martin, L. X. Xia and J. D. Gorham: TGF-beta 1 uses distinct mechanisms to inhibit IFNgamma expression in CD4(+) T cells at priming and at recall: Differential involvement of Stat4 and T-bet. J Immunol 174, 5950-5958 (2005) (Pubitemid 40663781)
30. P. R. Mangan, L. E. Harrington, D. B. O'Quinn, W. S. Helms, D. C. Bullard, C. O. Elson, R. D. Hatton, S. M. Wahl, T. R. Schoeb and C. T. Weaver: Transforming growth factor-[beta] induces development of the TH17 lineage. Nature 441, 231-234 (2006)
31. Ivanov, II, B. S. McKenzie, L. Zhou, C. E. Tadokoro, A. Lepelley, J. J. Lafaille, D. J. Cua and D. R. Littman: The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126, 1121-1133 (2006) (Pubitemid 44380299)
32. M.-L. Cho, J.-W. Kang, Y.-M. Moon, H.-J. Nam, J.-Y. Jhun, S.-B. Heo, H.-T. Jin, S.-Y. Min, J.-H. Ju, K.-S. Park, Y.-G. Cho, C.-H. Yoon, S.-H. Park, Y.-C. Sung and H.-Y. Kim: STAT3 and NF-{kappa}B Signal Pathway Is Required for IL-23-Mediated IL-17 Production in Spontaneous Arthritis Animal Model IL-1 Receptor Antagonist-Deficient Mice. J Immunol 176, 5652-5661 (2006)
33. E. Volpe, N. Servant, R. Zollinger, S. I. Bogiatzi, P. Hupe, E. Barillot and V. Soumelis: A critical function for transforming growth factor-[beta], interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses. Nat Immunol 9, 650-657 (2008) (Pubitemid 351712635)
34. E. V. Acosta-Rodriguez, G. Napolitani, A. Lanzavecchia and F. Sallusto: Interleukins 1[beta] and 6 but not transforming growth factor-[beta] are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 8, 942-949 (2007) (Pubitemid 47300008)
35. S. C. Liang, X. Y. Tan, D. P. Luxenberg, R. Karim, K. Dunussi-Joannopoulos, M. Collins and L. A. Fouser: Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203, 2271-2279 (2006) (Pubitemid 44498362)
36. Y. Chung, X. Yang, S. H. Chang, L. Ma, Q. Tian and C. Dong: Expression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes. Cell Res 16, 902-907 (2006) (Pubitemid 44764200)
37. R. Nurieva, X. O. Yang, G. Martinez, Y. Zhang, A. D. Panopoulos, L. Ma, K. Schluns, Q. Tian, S. S. Watowich, A. M. Jetten and C. Dong: Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448, 480-483 (2007) (Pubitemid 47123514)
38. T. Korn, E. Bettelli, W. Gao, A. Awasthi, A. Jager, T. B. Strom, M. Oukka and V. K. Kuchroo: IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells. Nature 448, 484-487 (2007) (Pubitemid 47123515)
39. R. Nurieva, X. O. Yang, G. Martinez, Y. Zhang, A. D. Panopoulos, L. Ma, K. Schluns, Q. Tian, S. S. Watowich, A. M. Jetten and C. Dong: Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448, 480-483 (2007) (Pubitemid 47123514)
40. D. Ma, X. Zhu, P. Zhao, C. Zhao, X. Li, Y. Zhu, L. Li, J. Sun, J. Peng, C. Ji and M. Hou: Profile of Th17 cytokines (IL-17, TGF-beta, IL-6) and Th1 cytokine (IFN-gamma) in patients with immune thrombocytopenic purpura. Ann Hematol 87, 899-904 (2008)
41. X. Zhu, D. Ma, J. Zhang, J. Peng, X. Qu, C. Ji and M. Hou: Elevated interleukin-21 correlated to Th17 and Th1 cells in patients with immune thrombocytopenia. J Clin Immunol 30, 253-259 (2010)
42. K. M. Dhodapkar, S. Barbuto, P. Matthews, A. Kukreja, A. Mazumder, D. Vesole, S. Jagannath and M. V. Dhodapkar: Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myeloma. Blood 112, 2878-2885 (2008)
43. Z. Z. Yang, A. J. Novak, S. C. Ziesmer, T. E. Witzig and S. M. Ansell: Malignant B cells skew the balance of regulatory T cells and TH17 cells in B-cell non-Hodgkin's lymphoma. Cancer Res 69, 5522-5530 (2009)
44. E. Ersvaer, K. Liseth, J. Skavland, B. T. Gjertsen and O. Bruserud: Intensive chemotherapy for acute myeloid leukemia differentially affects circulating TC1, TH1, TH17 and TREG cells. BMC Immunol 11, 38 (2010)
45. B. Oppmann, R. Lesley, B. Blom, J. C. Timans, Y. Xu, B. Hunte, F. Vega, N. Yu, J. Wang, K. Singh, F. Zonin, E. Vaisberg, T. Churakova, M. Liu, D. Gorman, J. Wagner, S. Zurawski, Y. Liu, J. S. Abrams, K. W. Moore, D. Rennick, R. de Waal-Malefyt, C. Hannum, J. F. Bazan and R. A. Kastelein: Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13, 715-725 (2000)
46. P. Puccetti, M. L. Belladonna and U. Grohmann: Effects of IL-12 and IL-23 on antigen-presenting cells at the interface between innate and adaptive immunity. Crit Rev Immunol, 22, 373-390 (2002) (Pubitemid 36548950)
47. C. Parham, M. Chirica, J. Timans, E. Vaisberg, M. Travis, J. Cheung, S. Pflanz, R. Zhang, K. P. Singh, F. Vega, W. To, J. Wagner, A.-M. O'Farrell, T. McClanahan, S. Zurawski, C. Hannum, D. Gorman, D. M. Rennick, R. A. Kastelein, R. de Waal Malefyt and K. W. Moore: A Receptor for the Heterodimeric Cytokine IL-23 Is Composed of IL-12R{beta}1 and a Novel Cytokine Receptor Subunit, IL-23R. J Immunol 168, 5699-5708 (2002) (Pubitemid 34556153)
48. S. Fruchtman: Stem cell transplantation. Mt Sinai J Med 70, 166-170 (2003) (Pubitemid 36575740)
49. S. Lee, B. S. Cho, S. Y. Kim, S. M. Choi, D. G. Lee, K. S. Eom, Y. J. Kim, H. J. Kim, C. K. Min, S. G. Cho, D. W. Kim, J. W. Lee, W. S. Min, W. S. Shin and C. C. Kim: Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease. Biol Blood Marrow Transplant 13, 1083-94 (2007) (Pubitemid 47215565)
50. R. Das, R. Komorowski, M. J. Hessner, H. Subramanian, C. S. Huettner, D. Cua and W. R. Drobyski: Blockade of interleukin-23 signaling results in targeted protection of the colon and allows for separation of graft-versus-host and graftversus-leukemia responses. Blood 115, 5249-5258 (2010)
51. B. Gruhn, J. Intek, N. Pfaffendorf, R. Zell, S. Corbacioglu, F. Zintl, J. F. Beck, K.-M. Debatin and D. Steinbach: Polymorphism of Interleukin-23 Receptor Gene But Not of NOD2/CARD15 Is Associated with Graft-versus-Host Disease after Hematopoietic Stem Cell Transplantation in Children. Biol Blood Marrow Transplant 15, 1571-1577 (2009)
52. C. Cocco, S. Canale, C. Frasson, E. Di Carlo, E. Ognio, D. Ribatti, I. Prigione, G. Basso and I. Airoldi: Interleukin (IL)-23 acts as anti-tumor agent on childhood B-acute lymphoblastic leukemia cells. Blood 116, 3887-3898 (2010)
53. X. Y. Zhang, H. J. Zhang, Y. Zhang, Y. J. Fu, J. He, L. P. Zhu, S. H. Wang and L. Liu: Identification and expression analysis of alternatively spliced isoforms of human interleukin-23 receptor gene in normal lymphoid cells and selected tumor cells. Immunogenetics 57, 934-943 (2006) (Pubitemid 43185428)
54. J. Massague, S. Cheifetz, M. Laiho, D. A. Ralph, F. M. Weis and A. Zentella: Transforming growth factor-beta. Cancer Surv 12, 81-103 (1992)
55. J. Massague: The TGF-beta family of growth and differentiation factors. Cell 49, 437-438 (1987)
56. Y. Shi and J. Massague: Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113, 685-700 (2003) (Pubitemid 36724933)
57. Y. Jiang, H. Liang, W. Guo, L. V. Kottickal and L. Nagarajan: Differential expression of a novel C-terminally truncated splice form of SMAD5 in hematopoietic stem cells and leukemia. Blood 95, 3945-3950 (2000) (Pubitemid 30412872)
58. Y. Imai, M. Kurokawa, K. Izutsu, A. Hangaishi, K. Maki, S. Ogawa, S. Chiba, K. Mitani and H. Hirai: Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis. Oncogene 20, 88-96 (2001) (Pubitemid 32142341)
59. A. Jakubowiak, C. Pouponnot, F. Berguido, R. Frank, S. Mao, J. Massagui and S. D. Nimer: Inhibition of the Transforming Growth Factor β1 Signaling Pathway by the AML1/ETO Leukemia-associated Fusion Protein. J Biol Chem, 275, 40282-40287 (2000) (Pubitemid 32064660)
60. Y. Y. Wang, G. B. Zhou, T. Yin, B. Chen, J. Y. Shi, W. X. Liang, X. L. Jin, J. H. You, G. Yang, Z. X. Shen, J. Chen, S. M. Xiong, G. Q. Chen, F. Xu, Y. W. Liu, Z. Chen and S. J. Chen: AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: Implication in stepwise leukemogenesis and response to Gleevec. Proc Natl Acad Sci USA 102, 1104-1109 (2005) (Pubitemid 40170733)
61. T. Terui, Y. Niitsu, K. Mahara, Y. Fujisaki, Y. Urushizaki, Y. Mogi, Y. Kohgo, N. Watanabe, M. Ogura and H. Saito: The production of transforming growth factor-beta in acute megakaryoblastic leukemia and its possible implications in myelofibrosis. Blood 75, 1540-1548 (1990) (Pubitemid 20114895)
62. P. P. Pandolfi: Oncogenes and tumor suppressors in the molecular pathogenesis of acute promyelocytic leukemia. Hum Mol Genet 10, 769-75 (2001) (Pubitemid 32331587)
63. A. Kakizuka, W. H. Miller, Jr., K. Umesono, R. P. Warrell, Jr., S. R. Frankel, V. V. Murty, E. Dmitrovsky and R. M. Evans: Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 66, 663-674 (1991) (Pubitemid 121001702)
64. U. Testa, R. Masciulli, E. Tritarelli, R. Pustorino, G. Mariani, R. Martucci, T. Barberi, A. Camagna, M. Valtieri and C. Peschle: Transforming growth factor-beta potentiates vitamin D3-induced terminal monocytic differentiation of human leukemic cell lines. J Immunol 150, 2418-2430 (1993) (Pubitemid 23127488)
65. H. K. Lin, S. Bergmann and P. P. Pandolfi: Cytoplasmic PML function in TGF-beta signalling. Nature 431, 205-211 (2004) (Pubitemid 39243475)
66. C. A. Dinarello: Interleukin-1 and interleukin-1 antagonism. Blood 77, 1627-1652 (1991)
67. P. Seckinger, J. Lowenthal, K. Williamson, J. Dayer and H. MacDonald: A urine inhibitor of interleukin 1 activity that blocks ligand binding. J Immunol 139, 1546-1549 (1987) (Pubitemid 17151588)
68. S. S. Shaftel, W. S. Griffin and M. K. O'Banion: The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective. J Neuroinflammation 5, 7 (2008)
69. F. Colotta, S. K. Dower, J. E. Sims and A. Mantovani: The type II [']decoy' receptor: A novel regulatory pathway for interleukin 1. Immunol Today 15, 562-566 (1994) (Pubitemid 24353906)
70. F. Cozzolino, A. Rubartelli, D. Aldinucci, R. Sitia, M. Torcia, A. Shaw and R. Di Guglielmo: Interleukin 1 as an autocrine growth factor for acute myeloid leukemia cells. Proc Natl Acad Sci USA 86, 2369-2373 (1989) (Pubitemid 19102510)
71. A. Rambaldi, M. Torcia, S. Bettoni, E. Vannier, T. Barbui, A. R. Shaw, C. A. Dinarello and F. Cozzolino: Modulation of cell proliferation and cytokine production in acute myeloblastic leukemia by interleukin-1 receptor antagonist and lack of its expression by leukemic cells. Blood 78, 3248-3253 (1991)
72. H. D. Preisler, A. Raza, C. Kukla, R. Larson, J. Goldberg and G. Browman: Interleukin-1 beta expression and treatment outcome in acute myelogenous leukemia. Blood 78, 849-850 (1991)
73. J. D. Griffin, A. Rambaldi, E. Vellenga, D. C. Young, D. Ostapovicz and S. A. Cannistra: Secretion of interleukin-1 by acute myeloblastic leukemia cells in vitro induces endothelial cells to secrete colony stimulating factors. Blood 70, 1218-1221 (1987) (Pubitemid 18022408)
74. Z. Estrov, R. Kurzrock, E. Estey, M. Wetzler, A. Ferrajoli, D. Harris, M. Blake, J. U. Gutterman and M. Talpaz: Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors. Blood 79, 1938-1945 (1992)
75. C. A. Dinarello and S. M. Wolff: The role of interleukin-1 in disease. N Engl J Med 328, 106-113 (1993)
76. C. A. Meyers, M. Albitar and E. Estey: Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer 104, 788-793 (2005) (Pubitemid 41113679)
77. T. Hirano, K. Yasukawa, H. Harada, T. Taga, Y. Watanabe, T. Matsuda, S.-i. Kashiwamura, K. Nakajima, K. Koyama, A. Iwamatsu, S. Tsunasawa, F. Sakiyama, H. Matsui, Y. Takahara, T. Taniguchi and T. Kishimoto: Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324, 73-76 (1986) (Pubitemid 16008419)
78. T. Kishimoto: The biology of interleukin-6. Blood 74, 1-10 (1989) (Pubitemid 19187402)
79. K. Yamasaki, T. Taga, Y. Hirata, H. Yawata, Y. Kawanishi, B. Seed, T. Taniguchi, T. Hirano and T. Kishimoto: Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. Science 241, 825-828 (1988)
80. P. C. Heinrich, I. Behrmann, G. Muller-Newen, F. Schaper and L. Graeve: Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J 334, 297-314 (1998) (Pubitemid 28448572)
81. C. E. van der Schoot, P. Jansen, M. Poorter, M. R. Wester, A. E. von dem Borne, L. A. Aarden and R. H. van Oers: Interleukin-6 and interleukin-1 production in acute leukemia with monocytoid differentiation. Blood 74, 2081-2087 (1989) (Pubitemid 19269114)
82. P. Koistinen, M. Saily, N. Poromaa and E. R. Savolainen: Complex effects of interleukin 6 on clonogenic blast cell growth in acute myeloblastic leukemia. Acta Haematol 98, 14-21 (1997) (Pubitemid 27248212)
83. K. A. Lord, A. Abdollahi, S. M. Thomas, M. DeMarco, J. S. Brugge, B. Hoffman-Liebermann and D. A. Liebermann: Leukemia inhibitory factor and interleukin-6 trigger the same immediate early response, including tyrosine phosphorylation, upon induction of myeloid leukemia differentiation. Mol Cell Biol 11, 4371-4379 (1991) (Pubitemid 21895831)
84. M. Lopez, N. Maroc, F. Kerangueven, F. Bardin, M. Courcoul, C. Lavezzi, F. Birg and P. Mannoni: Coexpression of the genes for interleukin 6 and its receptor without apparent involvement in the proliferation of acute myeloid leukemia cells. Exp Hematol 19, 797-803 (1991)
85. Y. M. Zhu, D. A. Bradbury, F. J. Keith and N. Russell: Absence of retinoblastoma protein expression results in autocrine production of interleukin-6 and promotes the autonomous growth of acute myeloid leukemia blast cells. Leukemia 8, 1982-1988 (1994) (Pubitemid 24363077)
86. F. Santiago-Schwarz, D. Coppock, A. Hindenburg and J. Kern: Identification of a malignant counterpart of the monocyte-dendritic cell progenitor in an acute myeloid leukemia. Blood 84, 3054-3062 (1994) (Pubitemid 24328098)
87. T. Lehrnbecher, T. Bernig, M. Hanisch, U. Koehl, M. Behl, D. Reinhardt, U. Creutzig, T. Klingebiel, S. J. Chanock and D. Schwabe: Common genetic variants in the interleukin-6 and chitotriosidase genes are associated with the risk for serious infection in children undergoing therapy for acute myeloid leukemia. Leukemia 19, 1745-1750 (2005) (Pubitemid 41486151)
88. E. Rouvier, M. F. Luciani, M. G. Mattei, F. Denizot and P. Golstein: CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J Immunol 150, 5445-5456 (1993) (Pubitemid 23180658)
89. C. T. Weaver, R. D. Hatton, P. R. Mangan and L. E. Harrington: IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 25, 821-852 (2007) (Pubitemid 46697925)
90. S. S. Watowich, H. Wu, M. Socolovsky, U. Klingmuller, S. N. Constantinescu and H. F. Lodish: Cytokine receptor signal transduction and the control of hematopoietic cell development. Annu Rev Cell Dev Biol 12, 91-128 (1996) (Pubitemid 26422710)
91. K. D. Liu, S. L. Gaffen and M. A. Goldsmith: JAK/STAT signaling by cytokine receptors. Curr Opin Immunol 10, 271-278 (1998) (Pubitemid 28286953)
92. S. V. Subramaniam, R. S. Cooper and S. E. Adunyah: Evidence for the involvement of JAK/STAT pathway in the signaling mechanism of interleukin-17. Biochem Biophys Res Commun 262, 14-19 (1999) (Pubitemid 29412615)
93. E. Tian, J. R. Sawyer, D. A. Largaespada, N. A. Jenkins, N. G. Copeland and J. D. Shaughnessy, Jr.: Evi27 encodes a novel membrane protein with homology to the IL17 receptor. Oncogene 19, 2098-109 (2000) (Pubitemid 30251375)
94. E. Ersvær, P. Hampson, K. Hatfield, E. Ulvestad, Ø. Wendelbo, J. Lord, B. Gjertsen and Ø. Bruserud: T cells remaining after intensive chemotherapy for acute myelogenous leukemia show a broad cytokine release profile including high levels of interferon-γ that can be further increased by a novel protein kinase C agonist PEP005. Cancer Immunol Immunother 56, 913-925 (2007) (Pubitemid 46723583)
95. P. Hampson, H. Chahal, F. Khanim, R. Hayden, A. Mulder, L. K. Assi, C. M. Bunce and J. M. Lord: PEP005, a selective small-molecule activator of protein kinase C, has potent antileukemic activity mediated via the delta isoform of PKC. Blood 106, 1362-1368 (2005) (Pubitemid 41129602)
96. T. Wrobel, G. Mazur, B. Jazwiec and K. Kuliczkowski: Interleukin-17 in acute myeloid leukemia. J Cell Mol Med 7, 472-474 (2003) (Pubitemid 44151698)
97. J. Parrish-Novak, S. R. Dillon, A. Nelson, A. Hammond, C. Sprecher, J. A. Gross, J. Johnston, K. Madden, W. Xu, J. West, S. Schrader, S. Burkhead, M. Heipel, C. Brandt, J. L. Kuijper, J. Kramer, D. Conklin, S. R. Presnell, J. Berry, F. Shiota, S. Bort, K. Hambly, S. Mudri, C. Clegg, M. Moore, F. J. Grant, C. Lofton-Day, T. Gilbert, F. Rayond, A. Ching, L. Yao, D. Smith, P. Webster, T. Whitmore, M. Maurer, K. Kaushansky, R. D. Holly and D. Foster: Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408, 57-63 (2000)
98. D. S. Mehta, A. L. Wurster, M. J. Whitters, D. A. Young, M. Collins and M. J. Grusby: IL-21 induces the apoptosis of resting and activated primary B cells. J Immunol 170, 4111-4118 (2003) (Pubitemid 36428174)
99. H. Asao, C. Okuyama, S. Kumaki, N. Ishii, S. Tsuchiya, D. Foster and K. Sugamura: Cutting Edge: The Common {{gamma}}-Chain Is an Indispensable Subunit of the IL-21 Receptor Complex. J Immunol 167, 1-5 (2001) (Pubitemid 32567752)
100. N. Akamatsu, Y. Yamada, H. Hasegawa, K. Makabe, R. Asano, I. Kumagai, K. Murata, Y. Imaizumi, K. Tsukasaki, K. Tsuruda, K. Sugahara, S. Atogami, K. Yanagihara and S. Kamihira: High IL-21 receptor expression and apoptosis induction by IL-21 in follicular lymphoma. Cancer Lett 256, 196-206 (2007) (Pubitemid 47418346)
101. A. C. Gowda, A. Ramanunni, C. Cheney, J. Roda, W. Kindsvogel, D. Henderson, S. pallavur, W. Carson, N. Muthusamy and J. C. Byrd: IL-21 enhances chemoimmunotherapy mediated death of chronic lymphocytic leukemia cells. J Clin Oncol 25, 7094 (2007)
102. A.-T. Brenne, T. Baade Ro, A. Waage, A. Sundan, M. Borset and H. Hjorth-Hansen: Interleukin-21 is a growth and survival factor for human myeloma cells. Blood 99, 3756-3762 (2002) (Pubitemid 34534548)